SG Americas Securities’s Olema Oncology, Inc. Common Stock OLMA Stock Holding History

SG Americas Securities’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Buy	+27,885	New	+$374K	﹤0.01%	2509
2026 Q1	–	Sell	-69,382	Closed	-$1.74M	–	3573
2025 Q4	$1.74M	Buy	+69,382	New	+$1.23M	﹤0.01%	1620
2025 Q2	–	Sell	-14,193	Closed	-$53K	–	3404
2025 Q1	$53K	Sell	14,193 -3,282	-19%	-$16.5K	﹤0.01%	3235
2024 Q4	$102K	Buy	17,475 +4,419	+34%	+$44.1K	﹤0.01%	2728
2024 Q3	$156K	Buy	+13,056	New	+$167K	﹤0.01%	2691
2024 Q1	–	Sell	-15,874	Closed	-$223K	–	3295
2023 Q4	$223K	Buy	15,874 +4,379	+38%	+$58.8K	﹤0.01%	2060
2023 Q3	$142K	Buy	+11,495	New	+$117K	﹤0.01%	2545
2021 Q4	–	Sell	-14,060	Closed	-$387K	–	3688
2021 Q3	$387K	Buy	+14,060	New	+$380K	﹤0.01%	2723
2021 Q1	–	Sell	-12,300	Closed	-$591K	–	3483
2020 Q4	$591K	Buy	+12,300	New	+$577K	﹤0.01%	1860

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

SG Americas Securities's OLMA Position: Q2 2026 in Review

SG Americas Securities opened a new position in Olema Oncology, Inc. Common Stock (OLMA) in Q2 2026: 27,885 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #2509 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in OLMA as recently as Q4 2025.

SG Americas Securities first reported a position in OLMA in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.74M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

SG Americas Securities held 27,885 shares of Olema Oncology, Inc. Common Stock worth $349K as of Q2 2026.
Olema Oncology, Inc. Common Stock was a new SG Americas Securities position in Q2 2026.
Olema Oncology, Inc. Common Stock made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2509 holding.
SG Americas Securities first reported a position in Olema Oncology, Inc. Common Stock in Q4 2020 and has held it in 9 quarters since.
SG Americas Securities's Olema Oncology, Inc. Common Stock position peaked at $1.74M in Q4 2025.
185 funds tracked by Wall St. Rank held Olema Oncology, Inc. Common Stock as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.